Implementation of a medicine management plan (MMP) to reduce medication-related harm (MRH) in older people post-hospital discharge: a randomised controlled trial.

ALI, Khalid, MENSAH, Ekow A., MCDERMOTT, Eugene Ace, KIRKHAM, Frances A., STEVENSON, Jennifer, HAMER, Victoria, PAREKH, Nikesh, SCHIFF, Rebekah, VAN DER CAMMEN, Tischa, NYANGOMA, Stephen, FOWLER-DAVIS, Sally, DAVIES, Graham and GAGE, Heather (2022). Implementation of a medicine management plan (MMP) to reduce medication-related harm (MRH) in older people post-hospital discharge: a randomised controlled trial. BMC Geriatrics, 22: 850.

Preview

PDF Fowler-Davis-ImplementationOfAMedicineManagementPlan(VoR).pdf - Published Version Creative Commons Attribution. Download (889kB) | Preview

Abstract

Background Medication-related harm (MRH) is an escalating global challenge especially among older adults. The period following hospital discharge carries high-risk for MRH due to medication discrepancies, limited patient/carer education and support, and poor communication between hospital and community professionals. Discharge Medical Service (DMS), a newly introduced NHS scheme, aims to reduce post-discharge MRH through an electronic communication between hospital and community pharmacists. Our study team has previously developed a risk-prediction tool (RPT) for MRH in the 8-weeks period post discharge from a UK hospital cohort of 1280 patients. In this study, we aim to find out if a Medicines Management Plan (MMP) linked to the DMS is more effective than the DMS alone in reducing rates of MRH. Method Using a randomized control trial design, 682 older adults ≥ 65years due to be discharged from hospital will be recruited from 4 sites. Participants will be randomized to an intervention arm (individualised medicine management plan (MMP) plus DMS) or a control arm (DMS only) using a 1:1 ratio stratification. Baseline data will include patients’ clinical and social demographics, and admission and discharge medications. At 8-weeks post-discharge, a telephone interview and review of GP records by the study pharmacist will verify MRH in both arms. An economic and process evaluation will assess the cost and acceptability of the study methods. Data Analysis Univariate analysis will be done for baseline variables comparing the intervention and control arms. A multivariate logistic regression will be done incorporating these variables. Economic evaluation will compare the cost-of-service use among the study arms and modelled to provide national estimates. Qualitative data from focus-group interviews will explore practitioners’ understanding, and acceptance of the MMP, DMS and the RPT. Conclusion This study will inform the use of an objective, validated RPT for MRH among older adults after hospital discharge, and provide a clinical, economic, and service evaluation of a specific medicines management plan alongside the DMS in the National Health Service (UK).

Item Type:	Article
Identification Number:	https://doi.org/10.1186/s12877-022-03555-w
Depositing User:	Justine Gavin
Date Deposited:	13 Oct 2022 16:11
Last Modified:	12 Oct 2023 09:15
URI:	https://shura.shu.ac.uk/id/eprint/30866

Actions (login required)

View Item

Downloads

Publication Metrics